MedPath
NMPA Approval

Rivaroxaban Tablets

国药准字H20234023

August 8, 2023

Drug Information

利伐沙班片

片剂

2.5mg

化学药品

August 8, 2023

Company Information

Applicant Company

天津滨海高新区滨海科技园惠新路29号

Manufacturing Company

天津滨海高新区滨海科技园惠新路29号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

利伐沙班片 - NMPA 批准文号 | MedPath